ARCHIVES

PV-10 Produces 51 Percent Response Rate in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

DCT Board Ok’s concept For In Vivo Combination Studies

November 23, 1990

NCI Advisory Group, Other Cancer Meetings

July 29, 1983

Sandra Horning elected ASCO president-elect.

February 27, 2004

NIH Establishes Women’s Health Office, Responds To Criticism

September 14, 1990

NIH Seeks Method For Allocating Research Funds, Determine Economic Impact By Disease Category

April 26, 1974

NCI Grant Funding: “Zone of Likelihood” Moves From 7th to 9th Percentile

November 30, 2012